Współczesna Onkologia
 
2/2026 vol. 30
Clinical guidelines for the management of cytostatic extravasation in children

Review paper

Patrycja Sosnowska-Sienkiewicz, Anna Łohynowicz, Danuta Januszkiewicz-Lewandowska

Contemp Oncol (Pozn) 2026; 30 (2): 103–109

DOI: https://doi.org/10.5114/wo.2026.163773
Abstract View text (PDF)
Low-grade appendiceal mucinous neoplasm vs. high-grade appendiceal mucinous neoplasm: similarities, differences, and current management challenges

Review paper

Paweł Lesiak, Bartosz Kapturkiewicz, Tomasz Jastrzębski, Marek Bębenek, Michał Kazanowski

Contemp Oncol (Pozn) 2026; 30 (2): 110–116

DOI: https://doi.org/10.5114/wo.2026.163813
Abstract View text (PDF)
Fibroblast growth factor receptor 1 status discordance between primary breast tumours and lymph node metastases is associated with peripheral blood circulating tumour cell burden

Original paper

Marcin Braun, Jakub Czerwiński, Julia Richert, Julia Sołek, Dominik Paprocki, Tomasz Labuk, Michał Maj, Cecilia Analia Panek, Dominika Piasecka, Joanna Zofia Chrobak-Bień, Dariusz Nejc, Agnieszka Wanda Piastowska-Ciesielska, Radzisław Kordek, Natalia Bednarz-Knoll, Rafal Sadej, Hanna Romanska

Contemp Oncol (Pozn) 2026; 30 (2): 117–125

DOI: https://doi.org/10.5114/wo.2026.163812
Abstract View text (PDF)
Serum lactate dehydrogenase and vascular endothelial growth factor A level as a predictor of treatment response in locally advanced-stage World Health Organisation type 3 nasopharyngeal carcinoma

Original paper

Mochammad Alfian Sulaksana, Abdul Qadar Punagi, Nova Audrey L Pieters, Hamsu Kadriyan

Contemp Oncol (Pozn) 2026; 30 (2): 126–133

DOI: https://doi.org/10.5114/wo.2026.163811
Abstract View text (PDF)
Anticancer effects of fangchinoline in 4T1 breast cancer cells: in vitro and in silico analysis of TGF-β1 and mTOR pathways

Original paper

Nicolas Kusady, Denny Satria, Poppy Anjelisa Zaitun Hasibuan, Dewi Pertiwi, Syukur Berkat Waruwu, Choo Yeun-Mun

Contemp Oncol (Pozn) 2026; 30 (2): 134–144

DOI: https://doi.org/10.5114/wo.2026.163119
Abstract View text (PDF)
Omitting the 5-fluorouracil bolus in metastatic colorectal cancer: impact on survival and toxicity in a retrospective multicentre cohort

Original article

Ahmed Sohaib, Eman H. Hebesh, Naglaa S. Elabd, Omnia Korani, Mohamed T. Amin, Huda I. Abd-Elhafiz, Amira M. Badawy, Samar Hosny

Contemp Oncol (Pozn) 2026; 30 (2): 145–156

DOI: https://doi.org/10.5114/wo.2026.162227
Abstract View text (PDF)
A clinicopathologic and survival analysis of mucoepidermoid carcinoma of the breast

Original paper

Omar Tluli, Mahd M. Abujbara, Eman E. Almaraghi, Dina Tluli, Giridhara Rathnaiah Babu, Semir Vranic

Contemp Oncol (Pozn) 2026; 30 (2): 157–169

DOI: https://doi.org/10.5114/wo.2026.163810
Abstract View text (PDF)
Artificial intelligence-driven body composition analysis and its association with survival in patients with colorectal liver metastases

Original paper

Miłosz Rozynek, Zbisław Tabor, Stanisław Kłęk, Tadeusz Popiela, Wadim Wojciechowski

Contemp Oncol (Pozn) 2026; 30 (2): 170–176

DOI: https://doi.org/10.5114/wo.2026.163047
Abstract View text (PDF)
Reirradiation and teclistamab in relapsed multiple myeloma: initial experience in two heavily pretreated patients with extensive disease

Case report

Carsten Nieder, Siri U Hansen, Terje S Solhaug, Randi F Hallstensen

Contemp Oncol (Pozn) 2026; 30 (2): 177–183

DOI: https://doi.org/10.5114/wo.2026.162045
Abstract View text (PDF)
SUBMIT YOUR PAPER
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications